Effect of LANCONONE in Weight-bearing Joint Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-16

Study Completion Date

2019-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study has been designed to primarily assess the effect of Lanconone® in comparison to placebo on pain in weight bearing joints.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Assess the Lanconone® (E-OA-07) Efficacy in Physical Activity-related Pain- LEAP Study

NCT03262805

Knee Osteoarthritis

COMPLETED NA

Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA

NCT02417506

Osteoarthritis of Knee

COMPLETED NA

To Assess the Efficacy of Collagen Supplement in Osteoarthritis

NCT04470336

Knee Osteoarthritis

COMPLETED NA

Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee

NCT03442153

Osteoarthritis, Knee

UNKNOWN NA

Probiotic for Pain Osteoarthritis

NCT03968770

Osteoarthritis of Multiple Joints

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteo Arthritis Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lanconone®

Lanconone®: 2 Capsules once a day after breakfast

Group Type ACTIVE_COMPARATOR

Lanconone®

Intervention Type DIETARY_SUPPLEMENT

2 capsules

Methyl Crystalline Cellulose

2 Capsules once a day after breakfast

Group Type PLACEBO_COMPARATOR

Methyl crystalline cellulose

Intervention Type DIETARY_SUPPLEMENT

2 Capsules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lanconone®

2 capsules

Intervention Type DIETARY_SUPPLEMENT

Methyl crystalline cellulose

2 Capsules

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. BMI ≥ 25 and ≤ 29.9 kg/m2.
2. With unilateral or bilateral OA of the knee for at least greater than 3 months, as presented by pain in the knee at least for last 3 months.
3. Post-menopausal females (LMP at least 12 months prior to the screening).

Exclusion Criteria

1. History of osteoarthritis for more than 3 years.
2. Systolic Blood Pressure ≥140 mm Hg and Diastolic Blood Pressure ≥ 90 mm Hg
3. FBS\>140 mg/dl.
4. Smokers or chronic alcoholics.
5. Participants planning to travel in the next 56 days or engage in any non-routine activity that is likely to strain the knees.

Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No